Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$935M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$606M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$598M |
| 4 |
Alibaba
BABA
|
+$340M |
| 5 |
SPDR Gold Trust
GLD
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$47.4M |
| 2 |
Linde
LIN
|
+$29.9M |
| 3 |
Walmart Inc
WMT
|
+$28.5M |
| 4 |
Microsoft
MSFT
|
+$28.4M |
| 5 |
Deere & Co
DE
|
+$26.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 24.27% |
| 2 | Consumer Discretionary | 16.92% |
| 3 | Healthcare | 15.14% |
| 4 | Financials | 5.73% |
| 5 | Industrials | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Philip Morris
PM
$295B
| $6.84M | 0.04% |
+72,137
| New | +$7.26M |
|
252
RH
RH
$3.71B
| $6.79M | 0.04% |
+10,185
| New | +$7.01M |
|
253
Encompass Health
EHC
$12.4B
| $6.72M | 0.04% |
112,573
-17,080
| -13% | -$1.07M |
|
254
Schrodinger
SDGR
$1.36B
| $6.67M | 0.04% |
121,982
-3,187
| -3% | -$204K |
|
|
SWAV
255
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $6.61M | 0.04% |
32,121
-2,732
| -8% | -$536K |
|
256
Ryder
R
$10.1B
| $6.55M | 0.04% |
79,177
+23,768
| +43% | +$1.83M |
|
257
MarketAxess Holdings
MKTX
$5.72B
| $6.51M | 0.04% |
15,487
-876
| -5% | -$402K |
|
258
Brown & Brown
BRO
$23.9B
| $6.47M | 0.04% |
116,641
-174
| -0.1% | -$9.7K |
|
259
Carter's
CRI
$1.47B
| $6.41M | 0.04% |
65,875
+16,919
| +35% | +$1.71M |
|
260
iQIYI
IQ
$1.28B
| $6.39M | 0.04% |
795,531
+333,336
| +72% | +$3.46M |
|
261
Coca-Cola Consolidated
COKE
$12.8B
| $6.29M | 0.03% |
159,570
-3,810
| -2% | -$152K |
|
262
AstraZeneca
AZN
$250B
| $6.26M | 0.03% |
52,117
+6,449
| +14% | +$751K |
|
263
HUTCHMED
HCM
$2.17B
| $6.24M | 0.03% |
170,551
+81,634
| +92% | +$3.21M |
|
264
Envista
NVST
$4.52B
| $6.17M | 0.03% |
147,568
-12,330
| -8% | -$520K |
|
265
Franklin Resources
BEN
$17.2B
| $6.14M | 0.03% |
206,654
+56,006
| +37% | +$1.75M |
|
|
SBNY
266
DELISTED
Signature Bank
SBNY
| $6.14M | 0.03% |
22,536
+4,887
| +28% | +$1.23M |
|
267
Floor & Decor
FND
$6.68B
| $6.08M | 0.03% |
50,324
+41,309
| +458% | +$4.93M |
|
|
WBA
268
DELISTED
Walgreens Boots Alliance
WBA
| $6.02M | 0.03% |
127,909
-33,229
| -21% | -$1.6M |
|
269
QuidelOrtho
QDEL
$838M
| $5.94M | 0.03% |
42,071
-2,102
| -5% | -$283K |
|
270
Adient
ADNT
$1.5B
| $5.91M | 0.03% |
142,568
+50,766
| +55% | +$2.02M |
|
|
API
271
Agora
API
$377M
| $5.83M | 0.03% |
201,037
+157,830
| +365% | +$4.92M |
|
272
Simply Good Foods
SMPL
$982M
| $5.8M | 0.03% |
168,293
-5,211
| -3% | -$187K |
|
273
Trex
TREX
$5.01B
| $5.7M | 0.03% |
55,876
+24,961
| +81% | +$2.61M |
|
274
Adobe
ADBE
$105B
| $5.67M | 0.03% |
9,851
-15,529
| -61% | -$9.77M |
|
275
STAAR Surgical
STAA
$1.21B
| $5.57M | 0.03% |
43,329
-3,324
| -7% | -$465K |
|
Similar funds
Ray Dalio's Q3 2021 Portfolio in Review
As of Q3 2021, Ray Dalio held 821 positions worth $18.3B, up 17% from $15.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Ray Dalio deployed $3.42B of net new capital in Q3 2021, opening 117 new positions and adding to 343 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 8,990,211 shares worth $70M.
By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Danaher, an estimated $47.4M trimmed.
- Ray Dalio's largest Q3 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 8,990,211 shares worth $70M.
- Ray Dalio added most to iShares MSCI Emerging Markets ETF in Q3 2021, an estimated $935M increase.
- Ray Dalio's biggest Q3 2021 reduction was Danaher, cutting an estimated $47.4M.
- Ray Dalio fully exited Linde in Q3 2021, selling an estimated $29.9M.
- Ray Dalio's ten largest holdings make up 38% of its $18.3B portfolio in Q3 2021.
- Ray Dalio opened 117 new positions and closed 138 in Q3 2021.
- Ray Dalio's portfolio value rose 17% quarter-over-quarter to $18.3B.
Based on Bridgewater Associates's 13F filing for Q3 2021, filed 12 Nov 2021.